Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
26
ADHC Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
11.96%
Day range:
$0.0006 - $0.0008
52-week range:
$0.0004 - $0.0037
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
10M
Avg. volume:
10.5M
1-year change:
-36.36%
Market cap:
$541.8K
Revenue:
--
EPS (TTM):
-$0.00
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $300 | $2.7K | $624.7K | $151.6K | $3.8K | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $150.3K | $693.9K | $624.7K | $205.4K | $455.2K | |
| Operating Income | -$150.3K | -$693.9K | -$624.7K | -$205.4K | -$455.2K | |
| Net Interest Expenses | $112.4K | $123.6K | $132.1K | $133.1K | $13.8K | |
| EBT. Incl. Unusual Items | -$262.8K | -$817.5K | -$756.8K | -$338.5K | -$469K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$262.8K | -$817.5K | -$756.8K | -$338.5K | -$469K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$262.8K | -$817.5K | -$756.8K | -$338.5K | -$469K | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Weighted Average Basic Share | $866.5M | $946.5M | $367.4M | $705.5M | $715.7M | |
| Weighted Average Diluted Share | $866.5M | $946.5M | $367.4M | $705.5M | $715.7M | |
| EBITDA | -$150.3K | -$694K | -$624.7K | -$205.4K | -$455.2K | |
| EBIT | -$150.3K | -$694K | -$624.7K | -$205.4K | -$455.2K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$150.3K | -$693.9K | -$624.7K | -$205.4K | -$455.2K | |
| Operating Income (Adjusted) | -$150.3K | -$694K | -$624.7K | -$205.4K | -$455.2K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.7K | $2.4K | $1.2K | $9K | $3.8K | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $40.9K | $2.4K | $1.2K | $41.3K | $227.6K | |
| Operating Income | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Net Interest Expenses | $30K | $32.7K | $33.7K | $13.3K | $400 | |
| EBT. Incl. Unusual Items | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Basic EPS (Cont. Ops) | -$0.00 | -- | -- | -- | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -- | -- | -- | -$0.00 | |
| Weighted Average Basic Share | $866.5M | $946.5M | $941.2M | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $866.5M | $946.5M | $941.2M | $1.3B | $1.3B | |
| EBITDA | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| EBIT | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Operating Income (Adjusted) | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $32.7K | $199.5K | $491.5K | $159.4K | $232.9K | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $162.2K | $199.5K | $491.5K | $245.5K | $641.5K | |
| Operating Income | -$162.2K | -$199.5K | -$491.5K | -$245.5K | -$641.5K | |
| Net Interest Expenses | $115.2K | $126.3K | $133.7K | $112.7K | $1.1K | |
| EBT. Incl. Unusual Items | -$277.5K | -$325.8K | -$625.1K | -$358.2K | -$642.4K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$277.5K | -$781.8K | -$756.6K | -$358.2K | -$642.4K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$277.5K | -$325.8K | -$625.1K | -$358.2K | -$642.4K | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.00 | -$0.00 | -$0.00 | -$0.00 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$162.2K | -$199.5K | -- | -$245.5K | -$641.5K | |
| EBIT | -$162.2K | -$199.5K | -$491.5K | -$245.5K | -$641.5K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$162.2K | -$199.5K | -$491.5K | -$245.5K | -$641.5K | |
| Operating Income (Adjusted) | -$162.2K | -$199.5K | -$491.5K | -$245.5K | -$641.5K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.7K | $2.4K | $1.2K | $9K | $3.8K | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $40.9K | $2.4K | $1.2K | $41.3K | $227.6K | |
| Operating Income | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Net Interest Expenses | $30K | $32.7K | $33.7K | $13.3K | $400 | |
| EBT. Incl. Unusual Items | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Basic EPS (Cont. Ops) | -$0.00 | -- | -- | -- | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.00 | -- | -- | -- | -$0.00 | |
| Weighted Average Basic Share | $866.5M | $946.5M | $941.2M | $1.3B | $1.3B | |
| Weighted Average Diluted Share | $866.5M | $946.5M | $941.2M | $1.3B | $1.3B | |
| EBITDA | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| EBIT | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Operating Income (Adjusted) | -$40.9K | -$2.4K | -$1.2K | -$41.3K | -$227.6K | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | -- | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $500 | -- | -- | $16K | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $500 | -- | -- | $16K | -- | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $1.5M | $1.5M | $61.2K | $61.2K | $61.2K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.5M | $1.5M | $61.2K | $77.2K | $61.2K | |
| Accounts Payable | $5.1K | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.7M | $3M | $3.1M | $3M | $491.6K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.7M | $3M | $3.1M | $3M | $491.6K | |
| Common Stock | $866.5K | $946.5K | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$1.2M | -$1.5M | -$3M | -$3M | -$438.7K | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.2M | -$1.5M | -$3M | -$3M | -$430.4K | |
| Total Liabilities and Equity | $1.5M | $1.5M | $61.2K | $77.3K | $61.2K | |
| Cash and Short Terms | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | -- | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $9.2K | $18.8K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | $9.2K | $18.8K | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | $1.5M | $1.5M | $61.2K | $61.2K | $61.2K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.5M | $1.5M | $61.2K | $70.4K | $79.9K | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $2.7M | $3.1M | $3.1M | $368.9K | $528.3K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.7M | $3.1M | $3.1M | $368.9K | $528.3K | |
| Common Stock | $946.5K | -- | -- | -- | -- | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.2M | -$1.6M | -$3.1M | -$298.5K | -$448.4K | |
| Total Liabilities and Equity | $1.5M | $1.5M | $61.2K | $70.4K | $79.9K | |
| Cash and Short Terms | -- | -- | -- | -- | -- | |
| Total Debt | -- | $1.5M | -- | -- | -- | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$262.8K | -$817.5K | -$756.8K | -$338.5K | -$469K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | $456K | $611.7K | $99K | $412K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$37.7K | -$134.6K | -$13K | -$161.8K | -$27.5K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $37.7K | $134.6K | $13K | $3.4K | $27.5K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -$158.5K | -- | |
| Ending Cash (CF) | -- | -- | -- | -$158.5K | -- | |
| Levered Free Cash Flow | -$37.7K | -$134.6K | -$13K | -$161.8K | -$27.5K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $456K | -- | -- | -- | $210K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$18.5K | -$2.4K | -$1.2K | -$2.1K | -$35.5K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $18.5K | $2.4K | $1.2K | $2.1K | $3.2K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$32.3K | |
| Ending Cash (CF) | -- | -- | -- | -- | -$32.3K | |
| Levered Free Cash Flow | -$18.5K | -$2.4K | -$1.2K | -$2.1K | -$35.5K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$277.5K | -$781.8K | -$756.6K | -$358.2K | -$642.4K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$54.2K | -$118.5K | -$11.8K | -$5.5K | -$60.9K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $54.2K | $118.5K | $11.8K | $5.5K | $28.6K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$54.2K | -$118.5K | -$11.7K | -$5.5K | -$60.9K | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$70.9K | -$35.1K | -$34.9K | -$54.6K | -$228K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $456K | -- | -- | -- | $210K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$18.5K | -$2.4K | -$1.2K | -$2.1K | -$35.5K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $18.5K | $2.4K | $1.2K | $2.1K | $3.2K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$32.3K | |
| Ending Cash (CF) | -- | -- | -- | -- | -$32.3K | |
| Levered Free Cash Flow | -$18.5K | -$2.4K | -$1.2K | -$2.1K | -$35.5K | |
Get ADHC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ADHC
Sector
P/E ratio
--
23.23x
PEG ratio
0.00x
-0.01x
P/B ratio
--
1.75x
Price / LTM sales
--
1.50x
Growth Metrics
ADHC
Sector
Revenue growth
--
3.24%
Earnings growth
--
10.12%
Revenue (5-year growth)
--
6.27%
Earnings forecast
--
-$0.19
Profitability
ADHC
Sector
Profitability FY 2025
--
$2.7M
Return on invested capital
--
-33.65%
Return on assets
-955.38%
-29.68%
Return on equity
--
-38.98%
Earnings Date
Last Earnings Date
Feb
11
Next Earnings Date
Feb
11
Estimated Next Earnings Date
May
13
Balance Sheet
ADHC
Sector
Total cash
--
$25M
Short term investments
--
$23.9M
Total assets
$61.2K
$72.5M
Long term debt
--
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
48
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 29x
Alerts
Buy
73
NKTR alert for Feb 11
Nektar Therapeutics [NKTR] is up 18.79% over the past day.
Buy
53
ICHR alert for Feb 11
Ichor Holdings Ltd. [ICHR] is up 5.08% over the past day.
Sell
26
MEDP alert for Feb 11
Medpace Holdings, Inc. [MEDP] is down 5.06% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
